After vehemently denying she had ever taken weight loss drugs, she finally admitted to taking them in a shock interview. Oprah lead the pack of celebrities flaunting much smaller physiques, alongside ...

Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to ...

Are GLP-1 weight-loss drugs a medical breakthrough or a ticking time bomb? The debate is louder than ever— hailed by some as ...

Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first ...

In this episode of 'Booked', top endocrinologist Dr. Ambrish Mithal unpacks the world of new-age weight-management drugs, ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

Amanda Bynes posted a short video where she discussed several life updates, including plans to dye her hair and start taking ...

If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...